(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
CAS No. 146504-07-6
(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine( —— )
Catalog No. M18038 CAS No. 146504-07-6
Cyclohexanediamine has a potential of anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 27 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclohexanediamine has a potential of anticancer activity.
-
DescriptionCyclohexanediamine has a potential of anticancer activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number146504-07-6
-
Formula Weight214.31
-
Molecular FormulaC11H22N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)OC(=O)N[C@@H]1CCCC[C@H]1N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tyrphostin AG 112
Tyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
-
AG-1517
PD153035 hydrochloride is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM in cell-free assays; little effect noted against PGDFR, FGFR, CSF-1, InsR and Src.
-
PD 089828
PD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 μM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 = 0.18 μM)
Cart
sales@molnova.com